Dyne Therapeutics IncNASDAQ:DYN
- LAST PRICE28.7800
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots27.0000/ 1
- Ask / Lots36.2400/ 2
- Open / Previous Close--- / 28.7800
- Day Range---
- 52 Week Range
- Volume60
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DYN |
|---|---|---|
| 09:32 ET | 19094 | 28.19 |
| 09:33 ET | 1150 | 28.06 |
| 09:35 ET | 20000 | 28.195 |
| 09:37 ET | 5900 | 28.18 |
| 09:39 ET | 5000 | 28.26 |
| 09:42 ET | 4844 | 28.215 |
| 09:44 ET | 415 | 28.233414 |
| 09:46 ET | 1713 | 28.52 |
| 09:48 ET | 2004 | 28.255 |
| 09:50 ET | 1522 | 28.285 |
| 09:51 ET | 985 | 28.39 |
| 09:53 ET | 935 | 28.39 |
| 09:55 ET | 200 | 28.295 |
| 09:57 ET | 692 | 28.36 |
| 10:00 ET | 200 | 28.225 |
| 10:02 ET | 1895 | 28.2425 |
| 10:06 ET | 200 | 28.33 |
| 10:08 ET | 2934 | 28.165 |
| 10:09 ET | 700 | 28.195 |
| 10:11 ET | 100 | 28.255 |
| 10:13 ET | 450 | 28.2 |
| 10:15 ET | 100 | 28.275 |
| 10:20 ET | 400 | 28.41 |
| 10:22 ET | 2500 | 28.57 |
| 10:24 ET | 100 | 28.57 |
| 10:26 ET | 400 | 28.62 |
| 10:27 ET | 100 | 28.61 |
| 10:29 ET | 1200 | 28.61 |
| 10:31 ET | 1175 | 28.75 |
| 10:33 ET | 300 | 28.67 |
| 10:36 ET | 3494 | 28.5 |
| 10:38 ET | 200 | 28.45 |
| 10:40 ET | 1600 | 28.535 |
| 10:42 ET | 1408 | 28.5 |
| 10:44 ET | 16932 | 28.51 |
| 10:45 ET | 1900 | 28.57 |
| 10:47 ET | 23824 | 28.67 |
| 10:49 ET | 6901 | 28.74 |
| 10:51 ET | 900 | 28.84 |
| 10:54 ET | 2600 | 28.9 |
| 10:56 ET | 300 | 28.9 |
| 10:58 ET | 630 | 29.04 |
| 11:00 ET | 2385 | 29.04 |
| 11:02 ET | 307 | 29 |
| 11:03 ET | 100 | 29 |
| 11:05 ET | 1700 | 29.065 |
| 11:07 ET | 2884 | 29.12 |
| 11:09 ET | 2349 | 29.09 |
| 11:12 ET | 4295 | 29.125 |
| 11:14 ET | 505 | 29.12 |
| 11:16 ET | 700 | 29.17 |
| 11:18 ET | 1617 | 29.09 |
| 11:20 ET | 1681 | 29.08 |
| 11:21 ET | 7022 | 28.86 |
| 11:23 ET | 900 | 28.87 |
| 11:25 ET | 5032 | 28.91 |
| 11:27 ET | 1100 | 28.87 |
| 11:30 ET | 1084 | 28.93 |
| 11:32 ET | 1568 | 28.99 |
| 11:34 ET | 2650 | 28.95 |
| 11:36 ET | 2170 | 28.92 |
| 11:38 ET | 3400 | 28.925 |
| 11:39 ET | 904 | 28.87 |
| 11:41 ET | 2896 | 28.8 |
| 11:43 ET | 900 | 28.83 |
| 11:45 ET | 1103 | 28.845 |
| 11:48 ET | 18829 | 28.88 |
| 11:50 ET | 1550 | 28.865 |
| 11:52 ET | 1718 | 28.83 |
| 11:54 ET | 1300 | 28.81 |
| 11:56 ET | 1094 | 28.79 |
| 11:57 ET | 1340 | 28.76 |
| 11:59 ET | 738 | 28.73 |
| 12:01 ET | 2092 | 28.785 |
| 12:03 ET | 1140 | 28.81 |
| 12:06 ET | 1000 | 28.775 |
| 12:08 ET | 900 | 28.815 |
| 12:10 ET | 2038 | 28.77 |
| 12:12 ET | 1600 | 28.775 |
| 12:14 ET | 704 | 28.8 |
| 12:15 ET | 800 | 28.83 |
| 12:17 ET | 950 | 28.815 |
| 12:19 ET | 606 | 28.835 |
| 12:21 ET | 1800 | 28.86 |
| 12:24 ET | 2260 | 28.92 |
| 12:26 ET | 500 | 28.93 |
| 12:28 ET | 520 | 28.97 |
| 12:30 ET | 2750 | 28.92 |
| 12:32 ET | 1200 | 28.995 |
| 12:33 ET | 1500 | 29.005 |
| 12:35 ET | 607 | 29 |
| 12:37 ET | 2681 | 29.05 |
| 12:39 ET | 1158 | 29.04 |
| 12:42 ET | 1050 | 29.03 |
| 12:44 ET | 400 | 29.04 |
| 12:46 ET | 795 | 29.045 |
| 12:48 ET | 800 | 29.1 |
| 12:50 ET | 1771 | 29.095 |
| 12:51 ET | 750 | 29.12 |
| 12:53 ET | 200 | 29.12 |
| 12:55 ET | 1597 | 29.12 |
| 12:57 ET | 3116 | 29.08 |
| 01:00 ET | 702 | 29.055 |
| 01:02 ET | 650 | 29.03 |
| 01:04 ET | 900 | 28.98 |
| 01:06 ET | 4524 | 29 |
| 01:08 ET | 550 | 29.02 |
| 01:09 ET | 310 | 28.98 |
| 01:11 ET | 809 | 29.02 |
| 01:13 ET | 645 | 29.01 |
| 01:15 ET | 1725 | 29 |
| 01:18 ET | 23944 | 29.155 |
| 01:20 ET | 1000 | 29.155 |
| 01:22 ET | 417 | 29.16 |
| 01:24 ET | 3947 | 29.07 |
| 01:26 ET | 2000 | 28.9691 |
| 01:27 ET | 687 | 28.95 |
| 01:29 ET | 462 | 28.85 |
| 01:31 ET | 655 | 28.865 |
| 01:33 ET | 500 | 28.89 |
| 01:36 ET | 744 | 28.88 |
| 01:38 ET | 749 | 28.88 |
| 01:40 ET | 2172 | 28.91 |
| 01:42 ET | 793 | 28.89 |
| 01:44 ET | 295 | 28.9 |
| 01:45 ET | 361 | 28.875 |
| 01:47 ET | 622 | 28.925 |
| 01:49 ET | 200 | 28.92 |
| 01:51 ET | 626 | 28.83 |
| 01:54 ET | 800 | 28.86 |
| 01:56 ET | 1100 | 28.84 |
| 01:58 ET | 400 | 28.87 |
| 02:00 ET | 1203 | 28.835 |
| 02:02 ET | 200 | 28.83 |
| 02:03 ET | 300 | 28.8 |
| 02:05 ET | 1500 | 28.79 |
| 02:07 ET | 614 | 28.8 |
| 02:09 ET | 200 | 28.82 |
| 02:12 ET | 3117 | 28.73 |
| 02:14 ET | 800 | 28.71 |
| 02:16 ET | 1100 | 28.715 |
| 02:18 ET | 2126 | 28.67 |
| 02:20 ET | 3665 | 28.705 |
| 02:21 ET | 1918 | 28.615 |
| 02:23 ET | 7900 | 28.68 |
| 02:25 ET | 1194 | 28.6162 |
| 02:27 ET | 337 | 28.665 |
| 02:30 ET | 4382 | 28.755 |
| 02:32 ET | 29193 | 28.78 |
| 02:34 ET | 11581 | 28.87 |
| 02:36 ET | 1357 | 28.88 |
| 02:38 ET | 846 | 28.86 |
| 02:39 ET | 400 | 28.865 |
| 02:41 ET | 1250 | 28.82 |
| 02:43 ET | 1938 | 28.85 |
| 02:45 ET | 561 | 28.83 |
| 02:48 ET | 609 | 28.86 |
| 02:50 ET | 200 | 28.82 |
| 02:52 ET | 4619 | 28.82 |
| 02:54 ET | 5292 | 28.86 |
| 02:56 ET | 8463 | 28.8925 |
| 02:57 ET | 1300 | 28.84 |
| 02:59 ET | 200 | 28.85 |
| 03:01 ET | 1418 | 28.865 |
| 03:03 ET | 7635 | 28.86 |
| 03:06 ET | 1700 | 28.84 |
| 03:08 ET | 1572 | 28.85 |
| 03:10 ET | 838 | 28.855 |
| 03:12 ET | 2774 | 28.85 |
| 03:14 ET | 2500 | 28.91 |
| 03:15 ET | 3266 | 28.875 |
| 03:17 ET | 4595 | 28.86 |
| 03:19 ET | 12744 | 28.97 |
| 03:21 ET | 1046 | 28.96 |
| 03:24 ET | 400 | 28.96 |
| 03:26 ET | 3761 | 29.05 |
| 03:28 ET | 2575 | 29.06 |
| 03:30 ET | 999 | 29.02 |
| 03:32 ET | 3011 | 28.96 |
| 03:33 ET | 22387 | 28.88 |
| 03:35 ET | 2934 | 28.87 |
| 03:37 ET | 2331 | 28.885 |
| 03:39 ET | 3079 | 28.83 |
| 03:42 ET | 4203 | 28.86 |
| 03:44 ET | 4542 | 28.96 |
| 03:46 ET | 28297 | 28.94 |
| 03:48 ET | 1400 | 28.915 |
| 03:50 ET | 2073 | 28.9 |
| 03:51 ET | 4017 | 28.86 |
| 03:53 ET | 6596 | 28.85 |
| 03:55 ET | 4580 | 28.82 |
| 03:57 ET | 31050 | 28.81 |
| 04:00 ET | 214554 | 28.78 |
Yesterday
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN, from 13 hours ago by Dow Jones
13 hours ago by Dow JonesThe Schall Law Firm Encourages Investor Participation In An Inquiry Into Dyne Therapeutics, Inc. For Possible Securities Law Violations, from 20 hours ago by Dow Jones
20 hours ago by Dow Jones
Nov 3, 2024
Dyne Therapeutics Inc Is Being Investigated For Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm, from 11:01AM ET on Sunday Nov 03, 2024 by Dow Jones
11:01AM ET on Sunday Nov 03, 2024 by Dow Jones
Nov 2, 2024
The Schall Law Firm Encourages Investor Participation In A Case Against Dyne Therapeutics, Inc. For Securities Law Violations, from 11:01AM ET on Saturday Nov 02, 2024 by Dow Jones
11:01AM ET on Saturday Nov 02, 2024 by Dow JonesSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN, from 11:00AM ET on Saturday Nov 02, 2024 by Dow Jones
11:00AM ET on Saturday Nov 02, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Dyne Therapeutics Inc | 2.9B | -8.0x | --- |
Janux Therapeutics Inc | 2.9B | -61.1x | --- |
MoonLake Immunotherapeutics | 3.0B | -51.3x | --- |
Vera Therapeutics Inc | 2.8B | -20.5x | --- |
Verona Pharma PLC | 3.1B | -24.6x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Company Information
Dyne Therapeutics Inc. is a clinical-stage muscle disease company. It is focused on advancing life-transforming therapeutics for people living with genetically driven diseases. It is utilizing its FORCE platform to overcome the limitations of muscle tissue delivery and oligonucleotide therapeutics for muscle diseases. Its FORCE platform therapeutics consist of an oligonucleotide payload that is designed to target the genetic basis of the disease. Using its FORCE platform, it is assembling a portfolio of muscle disease therapeutics, including its lead programs in myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD), and facioscapulohumeral dystrophy (FSHD). Its therapeutics consist of three components: a Fab, a clinically validated linker, and an oligonucleotide payload that it attaches to its Fab using the linker. It also plans to expand its portfolio through development efforts focused on rare skeletal muscle diseases, as well as cardiac and metabolic muscle diseases.
Contact Information
- Headquarters
- 1560 Trapelo RoadWALTHAM, MA, United States 02451
- Phone
- 781-786-8230
- Fax
- 781-786-8866
Executives
- Independent Chairman of the Board
- Jason Rhodes
- President, Chief Executive Officer, Director
- John Cox
- Chief Human Resource Officer
- Lucia Celona
- Senior Vice President, Head of Finance and Administration
- Richard Scalzo
- Chief Scientific Officer
- Oxana Beskrovnaya
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.9B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 100.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.10 |
EPS | $-3.58 |
Book Value | $1.49 |
P/E Ratio | -8.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
